About
Science & Technology
Partnership / Licensing
Investors
News
Contact
About
Science & Technology
Partnership / Licensing
Investors
News
Contact
News & Media
Blog
December 9, 2025
Benefits of a Prime-Only mRNA Vaccine for Pandemic Preparedness
Read More
December 2, 2025
MOP Platform for T Cell Targeting for Autoimmune and Cancer Applications through CAR-T Therapy
Read More
November 24, 2025
Adjuvants to Prevent Against Waning Immunity in mRNA Vaccines
Read More
November 3, 2025
MOP Platform as a Safety Solution for mRNA Vaccines: Addressing the need to avoid myocarditis and pericarditis
Read More
October 7, 2025
Multi-Organ Protection (MOP): Targeted mRNA, Safer Results
Read More
September 17, 2025
Versatility of the MOP Platform
Read More
See All
News
November 17, 2025
Strengthening Global IP for Next-Generation mRNA Innovation
Read More
November 3, 2025
New Data Reinforces the Potential of CTx’s MOP Adjuvant Technology for Respiratory Vaccines
Read More
October 6, 2025
October 13, 2025
October 16, 2025
Amsterdam, NL
CTx will attend World Vaccine Congress Europe in Amsterdam
Read More
September 10, 2025
September 15, 2025
September 19, 2025
Coronado, California
CTx at the 2nd Annual Meeting of Alliance for mRNA medicines
Read More
September 10, 2025
Robert Langer Rejoins the Board
Read More
September 10, 2025
Combined Therapeutics Joins the Alliance for mRNA Medicine
Read More
See All
Events
October 6, 2025
October 13, 2025
→
October 16, 2025
Amsterdam, NL
CTx will attend World Vaccine Congress Europe in Amsterdam
See All
©2025 Combined Therapeutics, Inc. All Rights Reserved.
Site created by
Insight Designs